| • |
Titel:
| BIG-register |
|
| • |
Titel:
| Bundesministerium für Gesundheit |
|
| • |
Titel:
| Department of Health UK |
|
| • |
Titel:
| DMOZ: opden directory project: Top: World: Nederlands: Maatschappij: Recht: Gezondheidsrecht |
|
| Auteur: | Universiteit van Tilburg | |
| • |
Titel:
| European Association of Health Law |
|
| Beschrijving: | The European Association of Health Law was established in 2007 by a group of health lawyers in academic institutions from around Europe to provide a forum for health lawyers from countries in the Council of Europe and beyond to discuss and collaborate on issues of importance in the development of health law and related policies.
This initiative is unique in that it is the only association of health lawyers that focuses on the contributions of Europe; it, thus, adds considerable value to the national and international bodies in this area.
The Mission Statement of the EAHL is “to strengthen the health and human rights interface throughout Europe, and to serve as an indispensable source of advice and guidance for the future of health law and policies in Europe.
| |
| • |
Titel:
| European Centre for Advanced Legal Studies in Healthcare |
|
| • |
Titel:
| Gezondheidsrecht |
|
| Auteur: | Recht.nl | |
| • |
Titel:
| Health Law resource |
|
| • |
Titel:
| Medisch Recht |
|
| Auteur: | KULeuven | |
| • |
Titel:
| New Jersey Law Network Disability Law |
|
| • |
Titel:
| New Jersey Law Network Health Law |
|
| • |
Titel:
| Patient Rights in the EU |
|
| Auteur: | Katholieke Universiteit Leuven | |
| • |
Titel:
| Patients' Rights Laws in Europe |
|
| • |
Titel:
| Premarket Approvals |
|
| Auteur: | Center for Devices and Radiological Health | |
| • |
Titel:
| Protection of persons in medical research: The netherlands |
|
| Auteur: | Hondius, E.H. | |
| Bron: | Universiteit Utrecht | |
| Gepubliceerd in: | Netherlands reports to the fifteenth international Congress of comparative law, II.A.4, p. 155-161 | |
| Jaar: | 1998 | |
| Beschrijving: | 90-5095-041-8, conference report | |
| Samenvatting: | On 19 March 1998, the Utrecht University Hospital (Academisch Ziekenhuis Utrecht) announced that in 1996 an international experiment with an anticoagulation drug had been halted after the death of seventeen patients. In the experiment, 1,316 patients participated, 665 of whom received aspirin to reduce the risk of a new stroke. The other 651 patients received the anticoagulation drug which aimed at preventing coagulation in the brain. Of the latter group, 53 patients had serious hemorrages and seventeen died. In the aspirin group six patients had similar complications and one died. The research team supposes that the anti-coagulation drug has diluted the blood too much, so it could leak away through damaged vascular walls. The experiment had been examined and approved by the medical ethical commissions of all 58 participating hospitals. After the first experiment was stopped, a new experiment with an adapted anti-coagulation drug was started, again after the approval of the 58 hospitals concerned. So far, only 135 patients – out of 4,500 needed – have agreed to participate. | |
| • |
Titel:
| Publicaties sectie Gezondheidsrecht |
|
| Auteur: | Instituut Beleid en Management Gezondheidszorg Erasmus Universiteit | |
| • |
Titel:
| Transgender law & Policy Institute |
|
| • |
Titel:
| US Department of Health and Human Services: National Institutes of Health |
|
| • |
Titel:
| Wet- en regelgeving |
|
| Auteur: | Centrum voor Ethiek en Gezondheid (ceg) | |
| • |
Titel:
| WHO - World Health Organization |
|
